Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Director · President and CEO | September 30, 2017 | October 03, 2017 |
| METLIFE INCMET · Entity 488 | Director | April 01, 2026 | April 03, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | May 20, 2026 | May 21, 2026 |
| VISA INC.V · Entity 495 | Director | January 27, 2026 | January 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date September 30, 2017 · Filed October 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 386,672 |
Ending reported balance
After 2017-09-30 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-09-30 · Tax withholding · Disposed 66,970 · Balance 341,281 Row 2 · 2017-09-30 · Grant · Acquired 20,559 · Balance 361,840 F1: On October 1, 2014, the Reporting Person was granted 82,238 RSUs that were subject to both performance-vesting and service-vesting requirements; the number of shares underlying these RSUs were reported on Form 4 at the time of grant at the target amount. Based on the level at which the performance goals were attained, the October 1, 2014 RSU grant vested at 125% on September 30, 2017, resulting in the Reporting Person receiving the additional shares reported above. Row 3 · 2017-09-30 · Grant · Acquired 24,832 · Balance 386,672 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.19 · Expires 2027-10-01 | Direct | 207,468 |
Reported balance
After 2017-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-10-01 · Grant · Acquired 207,468 · Balance 207,468 F3: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,165.27 |
Reported balance
Holding disclosure · report date 2017-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,165.27 F2: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2014, the Reporting Person was granted 82,238 RSUs that were subject to both performance-vesting and service-vesting requirements; the number of shares underlying these RSUs were reported on Form 4 at the time of grant at the target amount. Based on the level at which the performance goals were attained, the October 1, 2014 RSU grant vested at 125% on September 30, 2017, resulting in the Reporting Person receiving the additional shares reported above.
F2: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report.
F3: The options will vest in equal installments on each of the first three anniversaries of the Grant Date.
METLIFE INC
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,711 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 721 · Balance 34,711 F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
QUEST DIAGNOSTICS INC
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,929 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 11,929 F1: Represents an award of restricted stock units. F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units.
F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
VISA INC.
Report date January 27, 2026 · Filed January 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 10,133 |
Reported balance
After 2026-01-27 transaction · row 1
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 861 · Balance 10,133 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 166 | $185.25 | $30,750.99 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 8 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| November 20, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 35 | $181.51 | $6,352.94 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 7 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,367 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| November 18, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 1 | $179.65 | $179.65 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 6 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,332 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| October 17, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 10 | $178.09 | $1,780.90 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 5 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,331 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000172 · wf-form4_157004872032840.xml · derivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025.56 Underlying: Common Stock · 264 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:51 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 815 | $46.03 | $37,514.45 |
DisclosureSEC source: 0001099219-19-000217 · wf-form4_157013588868476.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,969 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| September 13, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | SaleClass A Common Stock | 6 | $177.07 | $1,062.41 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 4 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 23:00 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 1,000 | $171.13 | $171,129.90 |
DisclosureSEC source: 0001127602-19-026245 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,223 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 275 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000155 · wf-form4_156209918475466.xml · derivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754.92 Underlying: Common Stock · 275 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 20:54 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 770 | $48.71 | $37,506.70 |
DisclosureSEC source: 0001099219-19-000126 · wf-form4_156106407052496.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,154 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000134 · wf-form4_155803894745664.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 6 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:44 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022584 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,384 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 311 | $90.60 Strike: $0.00 | $28,176.60 |
DisclosureSEC source: 0001022079-19-000101 · wf-form4_155432355379454.xml · derivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474 Underlying: Common Stock · 311 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 163 | $86.63 Strike: $0.00 | $14,120.69 |
DisclosureSEC source: 0001022079-19-000028 · wf-form4_155070624899918.xml · derivative · entry 2 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163 Underlying: Common Stock · 163 shares Expires not disclosed F2 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 484 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000028 · wf-form4_155070624899918.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484 F1 · security: Represents an award of restricted share units. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 22:10 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 1,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003226 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Read SEC document |
| January 11, 2019 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 13 | $137.87 | $1,792.30 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 3 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:47 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002032 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,534 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:35 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 742 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-034204 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 742 Read SEC document |
| November 16, 2018 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 31 | $140.44 | $4,353.70 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 2 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 802 | $46.77 | $37,509.54 |
DisclosureSEC source: 0001209191-18-054022 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,634 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| August 17, 2018 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | SaleClass A Common Stock | 9 | $140.87 | $1,267.85 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:42 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037749 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,832 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:29 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023664 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,042 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:22 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001953 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,209 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055833 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,461 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 19:11 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantEmployee Stock Option (right to buy) · Derivative | 207,468 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0000016732-17-000061 · wf-form4_150705787943581.xml · derivative · entry 5 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,468 Underlying: Common Stock · 207,468 shares Expires 2027-10-01 F3 · derivative.exercise_date: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 19:11 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantCommon Stock | 24,832 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-17-000061 · wf-form4_150705787943581.xml · nonDerivative · entry 3 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,672 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 19:11 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantCommon Stock | 20,559 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-17-000061 · wf-form4_150705787943581.xml · nonDerivative · entry 2 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,840 F1 · shares: On October 1, 2014, the Reporting Person was granted 82,238 RSUs that were subject to both performance-vesting and service-vesting requirements; the number of shares underlying these RSUs were reported on Form 4 at the time of grant at the target amount. Based on the level at which the performance goals were attained, the October 1, 2014 RSU grant vested at 125% on September 30, 2017, resulting in the Reporting Person receiving the additional shares reported above. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 19:11 UTC | CAMPBELL'S Co CPB · Entity 3700 | Tax withholdingCommon Stock | 66,970 | $47.05 | $3,150,938.50 |
DisclosureSEC source: 0000016732-17-000061 · wf-form4_150705787943581.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,281 Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:24 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 704 | $53.31 | $37,530.24 |
DisclosureSEC source: 0001209191-17-040142 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,741 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 18:19 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantEmployee Stock Option (right to buy) · Derivative | 173,770 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0000016732-16-000147 · wf-form4_147560515084861.xml · derivative · entry 4 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,770 Underlying: Common Stock · 173,770 shares Expires 2026-10-01 F3 · derivative.exercise_date: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:19 UTC | CAMPBELL'S Co CPB · Entity 3700 | Tax withholdingCommon Stock | 44,000 | $54.38 | $2,392,720.00 |
DisclosureSEC source: 0000016732-16-000147 · wf-form4_147560515084861.xml · nonDerivative · entry 2 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,251 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:19 UTC | CAMPBELL'S Co CPB · Entity 3700 | Disposition to issuerCommon Stock | 42,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-16-000147 · wf-form4_147560515084861.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,251 F1 · shares: Represents number of shares previously reported as acquired by the reporting person that were forfeited because the performance criteria required for vesting were not met. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.